Rosen Law Firm announced a securities class action on behalf of investors who purchased common stock of CVRx, Inc. between July 25, 2023, and August 6, 2026, inclusive. The lawsuit alleges that CVRx made materially false or misleading statements about revenue growth, sales practices, regulatory compliance, reimbursement strategy, and sales-force productivity. It further alleges improper marketing of Barostim, kickbacks, and false information provided to government health insurance programs, potentially exposing the company to liability under the False Claims Act and Anti-Kickback Statute. The complaint also alleges that sales-force turnover remained elevated and productivity lagged despite assurances that the force had stabilized. Investors seeking lead-plaintiff status must move the court by January 8, 2027. No class has been certified, and the allegations have not been established by the court.